Review Article

Diagnostic Utility of CSF Tau and A ๐œท ๐Ÿ’ ๐Ÿ in Dementia: A Meta-Analysis

Table 1

Effect size, its 95% CI, and % weight calculations for each selected study of CSF tau in Alzheimerโ€™s disease and dementia due to other causes.

S. no.Authorโ€™s name and year Country where the studies were conducted Tau level (pg/mL) (AD and control) Effect size (pg/mL)95% CIWeight Tau level (pg/mL) (DOC and control) Effect size (pg/mL)95% CIWeight
DiseasedControlDiseasedControl
N SDN SDRMD+SEN SDN SDRMD+SE

1Arai et al. (1995) [15]Japan199193491994.5910.0080.07753.06โ€“1066.940.005777.245.51994.568.2017.2334.43โ€“101.970.215
2Tapiola et al. (1998) [16]Finland8152435133293140231.0045.99140.86โ€“321.140.0154040324833293140110.0046.1719.51โ€“200.490.030
3Galasko et al. (1998) [17]USA8266348160387167276.0057.33163.64โ€“388.360.010744563836038716769.0049.47โˆ’27.96โ€“165.960.026
4Andreasen et al. (1998) [18]Sweden437963821819057606.0059.78488.83โ€“723.170.009217083821819057518.0084.44352.51โ€“683.490.009
5Kanai et al. (1998) [19]Japan32489297.541217128272.0056.26161.73โ€“382.270.010332671464121712850.0032.34โˆ’13.38โ€“113.380.061
6Andreasen et al. (2001) [7]Sweden10575941718264102495.0047.27402.36โ€“587.640.0142346128018264102197.0063.1473.25โ€“320.750.016
7Sjรถgren et al. (2002) [20]Sweden1991934917342116577.0084.87410.67โ€“743.330.004153066517342116โˆ’36.0032.76โˆ’100.21โ€“28.210.059
8Grossman et al. (2005) [21]US17534.6303.513260.493.8274.2078.07121.18โ€“427.220.00573207.1270.313260.493.8โˆ’53.3040.95โˆ’133.58โ€“26.980.038
9de Jong et al. (2006) [22]The Netherlands616133263018489429.0044.79341.21โ€“516.790.016503033073018489119.0046.3628.14โ€“209.860.030
10Bibl et al. (2007) [23]Germany1570048015200130500.00128.40248.34โ€“751.660.0021534028015200130140.0079.71โˆ’16.22โ€“296.220.010
11Ravaglia et al. (2008) [24]Italy3156.332.73624.285.932.025.9620.35โ€“43.690.9091363.540.33624.285.939.2211.2217.23โ€“61.210.506

*Mean in diseased group, **Mean in control group and raw mean difference.